TriSalus Life Sciences announced the appointment of Riad Salem, M.D., to its Scientific Advisory Board. Dr. Salem is recognized as the Chief of Interventional Radiology and a Professor of Radiology, Surgery, and Medicine in Chicago.
Dr. Salem's expertise is expected to provide valuable insights into the company's oncology-focused medical technology business. His role will support the advancement of TriSalus's proprietary Pressure-Enabled Drug Delivery (PEDD) technology and its investigational immunotherapy, nelitolimod.
This appointment strengthens the company's scientific and clinical guidance, contributing to its mission of enhancing outcomes for patients with liver and pancreatic cancer through advanced delivery technology.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.